Anti-amphiphysin antibody positive autoimmune syndrome: case series and literature review
Frontiers in Immunology · 01.04.2026 · 17
DOI: 10.3389/fimmu.2026.1782004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 01.04.2026. Verfasst von Linran Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Nerve Tissue Proteins, Autoantibodies, Autoimmune Diseases, Paraneoplastic Syndromes, Nervous System. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and purpose Paraneoplastic neurological syndromes (PNS) is an uncommon disorder affecting the central nervous system (CNS), peripheral nervous system, or autonomic nervous system. The aim of this study was to analyze the clinical characteristics of anti-amphiphysin-IgG-positive autoimmune syndrome and to assess its association with a spectrum of anti-amphiphysin-IgG-associated autoimmune syndromes and tumors.
Methods
We reported clinical data of four patients with anti-amphiphysin-IgG-positive autoimmune syndrome, and conducted a literature review.
Result
Four amphiphysin-IgG-positive cases were identified. Within our cohort, antibodies feature was comprised of isolated amphiphysin-IgG (2/4), coexisting aquaporin-4-immunoglobulin G (AQP4-IgG) (1/4), coexisting N-methyl- D -aspartate receptor immunoglobulin G (NMDAR-IgG) (1/4). Clinical presentation included conus medullaris-cauda equina syndrome (1/4), myelitis (2/4) and stiff-person syndrome (SPS) (1/4). The coexisting cancer was involved of lung cancer (1/4).
Conclusion
Anti-amphiphysin-IgG-positive autoimmune syndrome demonstrate heterogeneous clinical presentations, including myelitis, SPS, and rare variants like conus medullaris-cauda equina syndrome. Coexistence with other neural antibodies (e.g., AQP4-IgG or NMDAR-IgG) may elevate tumor risk. While strongly associated with malignancies such as breast and small cell lung cancer (SCLC), combined immunotherapy and oncologic therapy can stabilize or improve neurological function in subsets of patients. Early serologic testing and sustained cancer surveillance are imperative for prompt intervention and prognostic optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Suzhou Hospital of Anhui Medical University, Suzhou Municipal Hospital of Anhui Province, Suzhou, China.
- Department of Genetics and Rare Diseases, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Neurological Rare Disease Biobank and Precision Diagnostic Technical Service Platform, Shanghai, China.
- Neurological Disorder Center, Haikou Orthopedic and Diabetes Hospital of Shanghai Sixth People's Hospital, Haikou, China.
- Shanghai Deji Hospital, Qingdao University, Qingdao, China.
Zitieren
APA
Wang, L., Chen, J., Tang, X., Yu, H., Guo, D., Chen, X., Cao, L., & Lu, K. (2026). Anti-amphiphysin antibody positive autoimmune syndrome: case series and literature review. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1782004
Vancouver
Wang L, Chen J, Tang X, Yu H, Guo D, Chen X, et al. Anti-amphiphysin antibody positive autoimmune syndrome: case series and literature review. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1782004
BibTeX
@article{Wang2026,
author = {Wang, Linran and Chen, Jingjiong and Tang, Xin and Yu, Haojun and Guo, Dandan and Chen, Xiaowei and Cao, Li and Lu, Kaili},
title = {Anti-amphiphysin antibody positive autoimmune syndrome: case series and literature review},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1782004}
}
EUVIMED